Connection

CULLEN TANIGUCHI to CRISPR-Cas Systems

This is a "connection" page, showing publications CULLEN TANIGUCHI has written about CRISPR-Cas Systems.
Connection Strength

0.129
  1. Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancer. JCI Insight. 2019 07 23; 5.
    View in: PubMed
    Score: 0.129
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.